Jade Clarson

CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Amy Hughes, Jade Clarson, Carine Tang et al. · Blood · 2017 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

Nadia El Khawanky, Amy Hughes, Wenbo Yu et al. · Nature Communications · 2021 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

Yazad Irani, Amy Hughes, Jade Clarson et al. · British Journal of Haematology · 2020 · 78 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia

Yazad Irani, Chung Hoow Kok, Jade Clarson et al. · Blood Advances · 2023 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced Natural Killer and Cytotoxic T Lymphocyte Responses, with Decreased Monocytic Myeloid Derived Suppressor Cells May Promote Treatment Free Remission in Chronic Myeloid Leukaemia Patients Following Tyrosine Kinase Inhibitor Cessation

Amy Hughes, Jade Clarson, Deborah L. White et al. · Blood · 2016 · 10 citations

Life Sciences, Hematology, Immunology +17